CLINICAL_TRIALS
trial_result
· 2017-10-10
Clinical Trial Update: Cimzia Versus Mesalamine for Crohn's Recurrence [Phase 4]
Summary
Phase 4 trial comparing Cimzia to mesalamine for Crohn's disease recurrence has been terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Milton S. Hershey Medical Center | Conditions: Crohn's Disease | Phase 4 | Status: TERMINATED | Results posted: 2017-10-10